Neuroblastoma Patient Still in Remission 18 Years After CAR-T Infusion

(MedPage Today) -- A woman diagnosed with neuroblastoma in childhood has remained in remission for more than 18 years after being treated with an engineered CAR T-cell therapy at 4 years of age, according to follow-up of a phase I trial.
Among...